Medical Professionals
Information for Healthcare Providers
Clinical Studies
Expanded Access
Educational Grants
Request Information
Press Releases
Suppliers
Skip to main content
Skip to footer
Atara Biotherapeutics
About
Company
Management Team
Board of Directors
Collaborators
Technology
Pipeline
Atara Pipeline
Tab-cel
®
ATA188
ATA2271/ATA3271
ATA3219
Patients & Families
Our Mission
Stories of Strength
About EBV
PTLD
Multiple Sclerosis
Clinical Studies
Expanded Access
Investors & Media
Investors & Media
News & Events
Financial Results
ATRA Stock
Analyst Coverage
SEC Filings
Governance
Careers
Careers Home
Career Areas
Tech Ops
Job Search
Contact
Medical Professionals
Press Releases
Suppliers
LinkedIn
Twitter
Search
Investors & Media
Investors & Media
Investors & Media
News & Events
Overview
Press Releases
Events
Presentations
Email Alerts
Investor & Media Contacts
Financial Results
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
ATRA Stock
Quote
Charts
Historical Data
FAQ
Classification Info
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Contact The Board
News
Careers
Presentations
News & Events
Overview
Press Releases
Events
Presentations
Email Alerts
Investor & Media Contacts
Investor Presentation
May 5, 2022
EBV and MS Day Presentation
Mar 22, 2022
ECTRIMS 2021 Investor Presentation
Oct 13, 2021
ECTRIMS 2020 Investor Presentation
Sep 11, 2020
EAN 2020 Investor Presentation
May 26, 2020
Email Alerts
Contacts
RSS News Feed
